HomePVCT • OTCMKTS
add
Provectus Biopharmaceuticals Inc
Previous close
$0.094
Day range
$0.096 - $0.098
Year range
$0.045 - $0.20
Market cap
43.16M USD
Avg Volume
201.39K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 14.33K | -88.17% |
Operating expense | 1.74M | 727.09% |
Net income | -2.40M | -261.30% |
Net profit margin | -16.72K | -2,953.07% |
Earnings per share | — | — |
EBITDA | -2.27M | -359.43% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 307.44K | 301.49% |
Total assets | 1.01M | -30.55% |
Total liabilities | 6.98M | -22.86% |
Total equity | -5.97M | — |
Shares outstanding | 420.28M | — |
Price to book | -9.44 | — |
Return on assets | -627.92% | — |
Return on capital | 210.04% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -2.40M | -261.30% |
Cash from operations | -912.01K | -62.51% |
Cash from investing | — | — |
Cash from financing | 788.42K | 291.17% |
Net change in cash | -124.46K | 67.54% |
Free cash flow | 93.39K | 120.95% |
About
Founded
2002
Headquarters
Website
Employees
6
